BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 32147549)

  • 61. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gene regulation network analysis reveals core genes associated with survival in glioblastoma multiforme.
    Jiang L; Zhong M; Chen T; Zhu X; Yang H; Lv K
    J Cell Mol Med; 2020 Sep; 24(17):10075-10087. PubMed ID: 32696617
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis.
    Ni M; Liu X; Wu J; Zhang D; Tian J; Wang T; Liu S; Meng Z; Wang K; Duan X; Zhou W; Zhang X
    Front Genet; 2018; 9():469. PubMed ID: 30369945
    [No Abstract]   [Full Text] [Related]  

  • 64. Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value.
    Zhou Y; Yang L; Zhang X; Chen R; Chen X; Tang W; Zhang M
    Biomed Res Int; 2019; 2019():6581576. PubMed ID: 31119182
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Screening prognosis-related genes in glioblastoma by microarray analysis.
    Wang H; Zhang Y; Zhang C; Tong X
    Anticancer Drugs; 2020 Feb; 31(2):150-157. PubMed ID: 31567312
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bioinformatics Analysis based on Multiple Databases Identifies Hub Genes Associated with Hepatocellular Carcinoma.
    Zeng L; Fan X; Wang X; Deng H; Zhang K; Zhang X; He S; Li N; Han Q; Liu Z
    Curr Genomics; 2019 Aug; 20(5):349-361. PubMed ID: 32476992
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Screening the Significant Hub Genes by Comparing Tumor Cells, Normoxic and Hypoxic Glioblastoma Stem-like Cell Lines Using Co-Expression Analysis in Glioblastoma.
    Güven E; Afzal M; Kazmi I
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328072
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis.
    Wei B; Wang L; Du C; Hu G; Wang L; Jin Y; Kong D
    Mol Med Rep; 2015 Apr; 11(4):2548-54. PubMed ID: 25514975
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A prognostic prediction system for hepatocellular carcinoma based on gene co-expression network.
    Guan L; Luo Q; Liang N; Liu H
    Exp Ther Med; 2019 Jun; 17(6):4506-4516. PubMed ID: 31086582
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
    Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
    Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aberrant Gene Expression Profiling in Men With Sertoli Cell-Only Syndrome.
    Chen T; Wang Y; Tian L; Guo X; Xia J; Wang Z; Song N
    Front Immunol; 2022; 13():821010. PubMed ID: 35833143
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of hub genes and pathways in glioblastoma by bioinformatics analysis.
    Yang S; Gao K; Li W
    Oncol Lett; 2019 Jan; 17(1):1035-1041. PubMed ID: 30655863
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of Hub Genes and Key Pathways Associated with Anti-
    Arya KR; Bharath Chand RP; Abhinand CS; Nair AS; Oommen OV; Sudhakaran PR
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of genes involved in the four stages of colorectal cancer: Gene expression profiling.
    Shi G; Wang Y; Zhang C; Zhao Z; Sun X; Zhang S; Fan J; Zhou C; Zhang J; Zhang H; Liu J
    Mol Cell Probes; 2018 Feb; 37():39-47. PubMed ID: 29179987
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anti-malarial drug dihydroartemisinin downregulates the expression levels of
    Hao L; Li S; Peng Q; Guo Y; Ji J; Zhang Z; Xue Y; Liu Y; Shi X
    Oncol Lett; 2021 Sep; 22(3):653. PubMed ID: 34386075
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of Hub Genes in Atypical Teratoid/Rhabdoid Tumor by Bioinformatics Analyses.
    Pan X; Liu W; Chai Y; Hu L; Wang J; Zhang Y
    J Mol Neurosci; 2020 Nov; 70(11):1906-1913. PubMed ID: 32440821
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decoding Psoriasis: Integrated Bioinformatics Approach to Understand Hub Genes and Involved Pathways.
    Choudhary S; Pradhan D; Khan NS; Singh H; Thomas G; Jain AK
    Curr Pharm Des; 2020; 26(29):3619-3630. PubMed ID: 32160841
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis.
    Li L; Liu X; Ma X; Deng X; Ji T; Hu P; Wan R; Qiu H; Cui D; Gao L
    Exp Ther Med; 2019 Nov; 18(5):3439-3449. PubMed ID: 31602219
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    Rong MH; Li JD; Zhong LY; Huang YZ; Chen J; Xie LY; Qin RX; He XL; Zhu ZH; Huang SN; Zhou XG
    Exp Biol Med (Maywood); 2022 Mar; 247(5):395-408. PubMed ID: 34743578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.